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REVIEWER
Ovidiu Chioncel UMF Carol Davila, Bucharest Romania REVIEW RETURNED 29-Jul-2018
GENERAL COMMENTS I want to congratulate the authors of "The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE) Prospective
Heart Failure Study Design" for their ambition to conduct such a study at national level.
I have some minor comments 1.how long will take enrolment process; if it will finish when overall sample size reaches 5000 its, it is possible as some hospitals to enrol very few patients while the hospitals a larger number. 
GENERAL COMMENTS
In the present paper authors describe an ongoing study, the The China PEACE 5p-HF Study, a longitudinal observational study aimed to dwexribe the care and the clinical outcomes and PROs from a diverse population of patients with HF in China. The study stared on august 2016. The protocol is adequately described data collection and mythological issues are appropriately addressed
VERSION 1 -AUTHOR RESPONSE
Reviewer #1:
Comment 1: how long will take enrolment process; if it will finish when overall sample size reaches 5000 its, it is possible as some hospitals to enrol very few patients while the hospitals a larger number. How investigators will deal with this issue?
Response: We started to enroll the first patients from August 2016 and finished the enrollment in May 2018. While some hospitals did enroll few patients because of their small treatment volumes (2 hospitals with less than 10 patients enrolled), we believe that it is important to have a sample of the care and outcomes from smaller institutions. This informed our statistical analysis plans. For overall estimates, we retained small-volume hospitals since their data represented treatment patterns in secondary hospitals. For analyses of hospital-level variation, we will exclude the 8 hospitals with fewer than 20 patients enrolled, to avoid imprecise estimates inappropriately influencing the variability across hospitals.
Comment 2: Do investigators have any data related to HF prevalence in China? OTHERWISE 5000 remains just a number.
Response: According to the Report on Cardiovascular Diseases in China 2017, it was estimated in 2000 that there were 4 million patients with chronic heart failure in China [Reference: National Center for Cardiovascular Diseases. Report on Cardiovascular Diseases in China. Encyclopedia of China Publishing House. 2017], however in our study we have no data able to estimate national estimates of the prevalence of heart failure throughout China. The key value of this longitudinal study is to prospectively assess the long-term clinical outcomes and patient-reported outcomes and determine the related predictors, which help to identify gaps in evidence-based care as targets for quality improvement. We assume that the reviewer was concerned about the representativeness of our study cohort, which we further explain in the response to the comment below. We have included sample size calculation in the Supplementary 9. We have added a sentence to describe the prevalence of HF in China in the Introduction section on page 6, line 4 as following:
It was estimated in 2000 that there were 4 million patients with chronic heart failure in China.
Comment 3: How many hospitals are in China to see representativity of "52 hospitals"?
Response: Similar to many other prospective HF studies, for example, ATTEND registry in Japan, GWTG-HF registry in US, and ESC-HF Pilot study in Europe, this study was based on a convenience sample of hospitals, rather than a national representative sample. However, we intentionally sought to sample across a variety of settings in China by including 52 secondary and tertiary hospitals located in 20 provinces of all the 3 economic-geographic regions (Western, Central and Eastern) in China. We believe that this intentional sampling provides rich (and the most detailed available) insight on the characteristics, treatment, outcomes of HF patients in China.
Comment 4: What type of hospitals are these: general, academic, with cardiac surgery.... Please cite methodology from ESC HF LT registry of HF pilot study to have an idea.
Response: We learned from ESC HF LT registry of HF pilot study to give information on types of hospitals. Hospitals in this study are diverse as we intentionally sought to reflect the care and outcomes of HF patients at different venues. Among 52 hospitals in this study, 48 are tertiary hospitals and 36 are medical college-affiliated hospitals. The median annual HF patient admission in 2015 was 500 (IQR 270, 1000) . We have added the details of type of hospitals in the Methods section on page 7, line 22 as following:
It is a prospective cohort study that will include 5000 patients hospitalized primarily for HF in 52 hospitals (48 are tertiary hospitals and 36 are medical college-affiliated hospitals) located in 20 provinces, covering all economic-geographic regions in China.
Besides patient-level information, we collected hospital-level information, including geographic region, hospital level (secondary or tertiary), teaching status, annual HF patient volume, the capacity to conduct biomarkers testing.
Comment 5: At physical examination, I suggest to include: heart rate, hepatomegaly, hepatojugular reflux, rates, and signs of hypo perfusion.
Response: We abstracted heart rate, hepatojugular reflux, pulmonary rales, and cardiogenic shock, which reflects hypoperfusion. We do not have data on hepatomegaly. These data have been included in Supplementary material 6 on pages 58, 61 and 62.
Reviewer #2:
In the present paper authors describe an ongoing study, the The China PEACE 5p-HF Study, a longitudinal observational study aimed to describe the care and the clinical outcomes and PROs from a diverse population of patients with HF in China.
The study stared on august 2016. The protocol is adequately described data collection and mythological issues are appropriately addressed.
Response: We thank the reviewer for supporting this study.
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REVIEWER
Ovidiu Chioncel IUBCV CC ILiescu, Romania REVIEW RETURNED 17-Dec-2018
GENERAL COMMENTS
The authors answered all my comments.
